Literature DB >> 12629509

The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.

Patrizia Ferrara1, Elisabetta Andermarcher, Guillaume Bossis, Claire Acquaviva, Frédérique Brockly, Isabelle Jariel-Encontre, Marc Piechaczyk.   

Abstract

c-fos gene is expressed constitutively in a number of tissues as well as in certain tumor cells and is inducible, in general rapidly and transiently, in virtually all other cell types by a variety of stimuli. Its protein product, c-Fos, is a short-lived transcription factor that heterodimerizes with various protein partners within the AP-1 transcription complex via leucine zipper/leucine zipper interactions for binding to specific DNA sequences. It is mostly, if not exclusively, degraded by the proteasome. To localize the determinant(s) responsible for its instability, we have conducted a genetic analysis in which the half-lives of c-Fos mutants and chimeras made with the stable EGFP reporter protein were compared under two experimental conditions taken as example of continous and inducible expression. Those were constitutive expression in asynchronously growing Balb/C 3T3 mouse embryo fibroblasts and transient induction in the same cells undergoing the G0/G1 phase transition upon stimulation by serum. Our work shows that c-Fos is degraded faster in synchronous- than in asynchronous cells. This difference in turnover is primarily accounted for by several mechanisms. First, in asynchronous cells, a unique C-terminal destabilizer is active whereas, in serum-stimulated cells two destabilizers located at both extremities of the protein are functional. Second, heterodimerization and/or binding to DNA accelerates protein degradation only during the G0/G1 phase transition. Adding another level of complexity to turnover control, phosphorylation at serines 362 and 374, which are c-Fos phosphorylation sites largely modified during the G0/G1 phase transition, stabilizes c-Fos much more efficiently in asynchronous than in serum-stimulated cells. In both cases, the reduced degradation rate is due to inhibition of the activity of the C-terminal destabilizer. However, in serum-stimulated cells, this effect is partially masked by the activation of the N-terminal destabilizer and basic domain/leucine zipper-dependent mechanisms. Taken together, our data show that multiple degradation mechanisms, differing according to the conditions of expression, may operate on c-Fos to ensure a proper level and/or timing of expression. Moreover, they also indicate that the half-life of c-Fos during the G0/G1 phase transition is determined by a delicate balance between opposing stabilizing and destabilizing mechanisms operating at the same time.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629509     DOI: 10.1038/sj.onc.1206266

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

Authors:  Guillaume Bossis; Cécile E Malnou; Rosa Farras; Elisabetta Andermarcher; Robert Hipskind; Manuel Rodriguez; Darja Schmidt; Stefan Muller; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

3.  c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics.

Authors:  Julia Adler; Nina Reuven; Chaim Kahana; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

Review 4.  Signaling in cell differentiation and morphogenesis.

Authors:  M Albert Basson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

5.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.

Authors:  Cécile E Malnou; Frédérique Brockly; Cyril Favard; Gabriel Moquet-Torcy; Marc Piechaczyk; Isabelle Jariel-Encontre
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

7.  miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.

Authors:  Carmen S Tellez; Daniel E Juri; Kieu Do; Maria A Picchi; Teresa Wang; Gang Liu; Avrum Spira; Steven A Belinsky
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

8.  Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.

Authors:  Miriam Kron; C James Howell; Ian T Adams; Michael Ransbottom; Diana Christian; Michael Ogier; David M Katz
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

9.  c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.

Authors:  Guillaume Bossis; Patrizia Ferrara; Claire Acquaviva; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.

Authors:  Varsha Rao; Bin Guan; Laura N Mutton; Charles J Bieberich
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.